Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages.

Andersson P, Harris SR, Smith HM, Hadfield J, O'Neill C, Cutcliffe LT, Douglas FP, Asche LV, Mathews JD, Hutton SI, Sarovich DS, Tong SY, Clarke IN, Thomson NR, Giffard PM.

Nat Commun. 2016 Feb 25;7:10688. doi: 10.1038/ncomms10688.

2.

Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey.

West SK, Munoz B, Weaver J, Mrango Z, Dize L, Gaydos C, Quinn TC, Martin DL.

PLoS Negl Trop Dis. 2016 Jan 15;10(1):e0004352. doi: 10.1371/journal.pntd.0004352. eCollection 2016 Jan.

3.

Clearing the trichiasis backlog: experiences in Amhara, Ethiopia.

Habtamu E, Burton M.

Community Eye Health. 2015;28(90):38. No abstract available.

4.

Estimating the Future Impact of a Multi-Pronged Intervention Strategy on Ocular Disease Sequelae Caused by Trachoma: A Modeling Study.

Gambhir M, Grassly NC, Burton MJ, Solomon AW, Taylor HR, Mabey DC, Blake IM, Basáñez MG.

Ophthalmic Epidemiol. 2015;22(6):394-402. doi: 10.3109/09286586.2015.1081249.

5.

Interventions for trachoma trichiasis.

Burton M, Habtamu E, Ho D, Gower EW.

Cochrane Database Syst Rev. 2015 Nov 13;11:CD004008. doi: 10.1002/14651858.CD004008.pub3. Review.

6.

Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma.

Ho DK, Sawicki C, Grassly N.

J Trop Med. 2015;2015:917370. doi: 10.1155/2015/917370. Epub 2015 Oct 18. Review.

7.
8.

Bacterial isolates and their antimicrobial susceptibility pattern among patients with external ocular infections at Borumeda hospital, Northeast Ethiopia.

Shiferaw B, Gelaw B, Assefa A, Assefa Y, Addis Z.

BMC Ophthalmol. 2015 Aug 14;15:103. doi: 10.1186/s12886-015-0078-z.

9.

Health Beliefs and Perceptions of Trachoma in Communities on the Bijagos Archipelago of Guinea Bissau.

Thompson K, Hutchins H, Baio A, Cassama E, Nabicassa M, Bailey R, Last AR.

Ophthalmic Epidemiol. 2015;22(3):190-9. doi: 10.3109/09286586.2015.1036889.

10.

Baseline Trachoma Mapping in Malawi with the Global Trachoma Mapping Project (GTMP).

Kalua K, Phiri M, Kumwenda I, Masika M, Pavluck AL, Willis R, Mpyet C, Lewallen S, Courtright P, Solomon AW; Global Trachoma Mapping Project.

Ophthalmic Epidemiol. 2015;22(3):176-83. doi: 10.3109/09286586.2015.1035793.

11.

Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.

West SK, Munoz BE, Mkocha H, Gaydos C, Quinn T.

Ophthalmic Epidemiol. 2015;22(3):170-5. doi: 10.3109/09286586.2015.1010687.

12.

Exposure to an Indoor Cooking Fire and Risk of Trachoma in Children of Kongwa, Tanzania.

Zambrano AI, Muñoz BE, Mkocha H, West SK.

PLoS Negl Trop Dis. 2015 Jun 5;9(6):e0003774. doi: 10.1371/journal.pntd.0003774. eCollection 2015.

13.

Prevalence of Active Trachoma and Its Associated Factors among Rural and Urban Children in Dera Woreda, Northwest Ethiopia: A Comparative Cross-Sectional Study.

Alemayehu M, Koye DN, Tariku A, Yimam K.

Biomed Res Int. 2015;2015:570898. doi: 10.1155/2015/570898. Epub 2015 Mar 25.

14.

Short term outcome of anterior lamellar reposition in treating trachomatous trichiasis.

Ahmed RA, Abdelbaky SH.

J Ophthalmol. 2015;2015:568363. doi: 10.1155/2015/568363. Epub 2015 Mar 31.

15.

Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.

Harding-Esch E, Jofre-Bonet M, Dhanjal JK, Burr S, Edwards T, Holland M, Sillah A, West S, Lietman T, Keenan J, Mabey D, Bailey R.

PLoS Negl Trop Dis. 2015 Apr 22;9(4):e0003670. doi: 10.1371/journal.pntd.0003670. eCollection 2015 Apr.

16.

Epilation for minor trachomatous trichiasis: four-year results of a randomised controlled trial.

Habtamu E, Rajak SN, Tadesse Z, Wondie T, Zerihun M, Guadie B, Gebre T, Kello AB, Callahan K, Mabey DC, Khaw PT, Gilbert CE, Weiss HA, Emerson PM, Burton MJ.

PLoS Negl Trop Dis. 2015 Mar 13;9(3):e0003558. doi: 10.1371/journal.pntd.0003558. eCollection 2015 Mar.

17.

Serology for trachoma surveillance after cessation of mass drug administration.

Martin DL, Bid R, Sandi F, Goodhew EB, Massae PA, Lasway A, Philippin H, Makupa W, Molina S, Holland MJ, Mabey DC, Drakeley C, Lammie PJ, Solomon AW.

PLoS Negl Trop Dis. 2015 Feb 25;9(2):e0003555. doi: 10.1371/journal.pntd.0003555. eCollection 2015 Feb.

18.

Whole-genome enrichment and sequencing of Chlamydia trachomatis directly from clinical samples.

Christiansen MT, Brown AC, Kundu S, Tutill HJ, Williams R, Brown JR, Holdstock J, Holland MJ, Stevenson S, Dave J, Tong CY, Einer-Jensen K, Depledge DP, Breuer J.

BMC Infect Dis. 2014 Nov 12;14:591. doi: 10.1186/s12879-014-0591-3.

19.

A randomised controlled trial to investigate effects of enhanced supervision on primary eye care services at health centres in Kenya, Malawi and Tanzania.

Kalua K, Gichangi M, Barassa E, Eliah E, Lewallen S, Courtright P.

BMC Health Serv Res. 2014;14 Suppl 1:S6. doi: 10.1186/1472-6963-14-S1-S6. Epub 2014 May 12.

20.

Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment.

Yohannan J, He B, Wang J, Greene G, Schein Y, Mkocha H, Munoz B, Quinn TC, Gaydos C, West SK.

Invest Ophthalmol Vis Sci. 2014 Jun 6;55(7):4144-50. doi: 10.1167/iovs.14-14148.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk